Consumer Believability of Information in Direct-to-Consumer (DTC) Advertising of Prescription Drugs

Author: Beltramini, Richard¹

Source: Journal of Business Ethics, Volume 63, Number 4, February 2006 , pp. 333-343(11)

Publisher: Springer

Purchase options

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$47.00 plus tax Refund Policy

More like this?

In this: publication
By this: publisher
In this Subject: Business
By this author: Beltramini, Richard

Content Key:

- Free

- New

- Open Access

- Subscribed

- Free Trial

Abstract:

Direct to consumer (DTC) advertising has attracted significant research attention, yet none has focused on empirical assessments of its overall impact on U.S. consumers nationally, and tying assessment to relevant behavioral outcomes. This paper addresses the ethical issue of DTC advertising providing a balance of product and risk information that is both understandable and believable, and contributes direction to those exploring this phenomenon.

Keywords: advertising effectiveness; believability; benefit-risk information balance; direct to consumer (DTC); patient-doctor relationship; public policy regulation; prescription drugs

Document Type: Research article

DOI: 10.1007/s10551-005-4711-2

Affiliations: 1: Email: R_BELTRAMINI@WAYNE.EDU